BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15118416)

  • 1. hCDC4 and genetic instability in cancer.
    Rajagopalan H; Lengauer C
    Cell Cycle; 2004 Jun; 3(6):693-4. PubMed ID: 15118416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of hCDC4 can cause chromosomal instability.
    Rajagopalan H; Jallepalli PV; Rago C; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C
    Nature; 2004 Mar; 428(6978):77-81. PubMed ID: 14999283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hCDC4 gene mutation is rare in colorectal carcinomas in Korean patients.
    Lee JW; Jeong EG; Lee SH; Yoo NJ; Lee SH
    Pathology; 2008 Apr; 40(3):305. PubMed ID: 18428053
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.
    Barber TD; McManus K; Yuen KW; Reis M; Parmigiani G; Shen D; Barrett I; Nouhi Y; Spencer F; Markowitz S; Velculescu VE; Kinzler KW; Vogelstein B; Lengauer C; Hieter P
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3443-8. PubMed ID: 18299561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hCDC4 variation in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Seto KK; Bell RS; Andrulis IL
    Cancer Genet Cytogenet; 2006 Sep; 169(2):138-42. PubMed ID: 16938571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.
    Ekholm-Reed S; Spruck CH; Sangfelt O; van Drogen F; Mueller-Holzner E; Widschwendter M; Zetterberg A; Reed SI
    Cancer Res; 2004 Feb; 64(3):795-800. PubMed ID: 14871801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability.
    Kemp Z; Rowan A; Chambers W; Wortham N; Halford S; Sieber O; Mortensen N; von Herbay A; Gunther T; Ilyas M; Tomlinson I
    Cancer Res; 2005 Dec; 65(24):11361-6. PubMed ID: 16357143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Fbxw7/hCdc4 tumor suppressor in human cancer.
    Tan Y; Sangfelt O; Spruck C
    Cancer Lett; 2008 Nov; 271(1):1-12. PubMed ID: 18541364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers.
    Nishida N; Nagasaka T; Kashiwagi K; Boland CR; Goel A
    Cancer Biol Ther; 2007 Apr; 6(4):525-33. PubMed ID: 17457043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.
    Grim JE
    Gut; 2014 May; 63(5):707-9. PubMed ID: 24000292
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
    Kothari N; Teer JK; Abbott AM; Srikumar T; Zhang Y; Yoder SJ; Brohl AS; Kim RD; Reed DR; Shibata D
    Cancer; 2016 Sep; 122(18):2828-35. PubMed ID: 27244218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FBXW7 and DNA copy number instability.
    Byrd KN; Huey B; Roydasgupta R; Fridlyand J; Snijders AM; Albertson DG
    Breast Cancer Res Treat; 2008 May; 109(1):47-54. PubMed ID: 17588203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
    Koh MS; Ittmann M; Kadmon D; Thompson TC; Leach FS
    Cancer Biol Ther; 2006 Jan; 5(1):78-83. PubMed ID: 16357515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage and tumour suppression.
    Berger AH; Knudson AG; Pandolfi PP
    J Pathol; 2012 Jun; 227(2):e1; author reply e2. PubMed ID: 22488586
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutational analysis of the hCDC4 gene in gastric carcinomas.
    Lee JW; Soung YH; Kim HJ; Park WS; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    Eur J Cancer; 2006 Sep; 42(14):2369-73. PubMed ID: 16824748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
    Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
    Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance.
    Iwatsuki M; Mimori K; Ishii H; Yokobori T; Takatsuno Y; Sato T; Toh H; Onoyama I; Nakayama KI; Baba H; Mori M
    Int J Cancer; 2010 Apr; 126(8):1828-1837. PubMed ID: 19739118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.
    Malyukova A; Dohda T; von der Lehr N; Akhoondi S; Corcoran M; Heyman M; Spruck C; Grandér D; Lendahl U; Sangfelt O
    Cancer Res; 2007 Jun; 67(12):5611-6. PubMed ID: 17575125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.
    Bailey ML; Singh T; Mero P; Moffat J; Hieter P
    Genetics; 2015 Nov; 201(3):885-95. PubMed ID: 26354767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
    Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.